Rheumatoid Arthritis News and Research

Latest Rheumatoid Arthritis News and Research

Pomegranate fruit extracts can block enzymes that contribute to osteoarthritis

The study looked at the ability of an extract of pomegranate fruit against Interleukin-1b (IL-1b), a pro-inflammatory protein molecule that plays a key role in cartilage degradation in osteoarthritis.

1 Sep 2005

Disease modifying activity of 2ME2 demonstrated in preclinical rheumatoid arthritis studies

EntreMed a clinical-stage pharmaceutical company developing therapeutics primarily for the treatment of cancer and inflammatory diseases, has announced the presentation of positive preclinical results for its lead compound, 2-methoxyestradiol (2ME2), in models of rheumatoid arthritis.

24 Aug 2005

Patients with primary biliary cirrhosis who are treated with methotrexate have an increased risk of death

In five randomized controlled trials involving 457 people, the authors report that for patients treated with methotrexate, as a single therapy or in combination with other drug treatment, pooled data showed a tendency toward an increased risk of death or liver transplantation. The brand names for methotrexate are Rheumatrex and Trexall.

23 Aug 2005

New research says brightly-coloured fruit and veggies protects against arthritis

Apparently rheumatoid arthritis currently affects around 1% adults in the UK, and previous studies have suggested that vitamin C and the pigment beta-cryptoxanthin, both of which are found in brightly-coloured fruit and vegetables, may act as antioxidants, and protect the body against the oxidative damage which can cause inflammation.

22 Aug 2005

Brightly-coloured fruit and veg, may act as antioxidants - protect against rheumatoid arthritis

Rheumatoid arthritis currently affects around 1% adults in the UK. Previous studies have suggested that vitamin C and the pigment beta-cryptoxanthin, both of which are found in brightly-coloured fruit and veg, may act as antioxidants, and protect the body against the oxidative damage which can cause inflammation.

From The University of Manchester 17 Aug 2005

Discovery of gene that controls the speed at which patients develop tuberculosis

Scientists at the Research Institute of the McGill University Health Centre (RI MUHC) have discovered a gene that controls the speed at which patients develop tuberculosis--the first time such a gene has been discovered for this disease.

16 Aug 2005

New hope for those deaf from immune system attack

A new study may one day help those deafened by immune system attack, and possibly also lead to a test that could show which patients may be helped by immediate steroid treatment.

16 Aug 2005

Adalimumab and methotrexate is about five times more effective than methotrexate alone for rheumatoid arthritis

For people with long-standing rheumatoid arthritis, combined treatment with the new "biologic" drug adalimumab and methotrexate is about five times more effective than methotrexate alone, according to a new systematic review of studies.

15 Aug 2005

Abbott receives European approval to market Humira

Abbott has announced that it has received approval from the European Commission to market Humira (adalimumab) as a treatment for psoriatic arthritis and early rheumatoid arthritis (RA) in Europe.

15 Aug 2005

Scientists discover how an HIV protein fragment shuts down an immune response

The HIV virus hides out in the very immune system cells that are meant to protect the body from viral infection. But how does it prevent these cells from mounting a full-scale attack against the invader?

11 Jul 2005

Patients with rheumatoid arthritis are at increased risk of coronary artery disease

The findings of research published today in Arthritis Research & Therapy show that CAD is accelerated in RA patients, and patients with both RA and CAD are at an increased risk of death from heart disease.

28 Jun 2005

Enzyme known as cathepsin G may be a target for anti-inflammatory treatments

The finding by researchers at Washington University School of Medicine in St. Louis shows that an enzyme known as cathepsin G regulates the ability of immune cells known as neutrophils to secrete chemicals that attract other immune cells and start the local inflammatory process. Over time, the excessive accumulation of immune cells can lead to tissue and cartilage damage in joints, causing pain and limiting mobility.

27 Jun 2005

Expression profiles and functional analyses of Wnt-related genes in human joint disorders

The cellular signaling protein Wnt, which is involved in embryonic development and cancer, contributes to disease progression of both rheumatoid arthritis and osteoarthritis.

26 Jun 2005

Immunomedics awarded U.S. and Australian patents

Immunomedics announced that it has received notices that the U.S. and Australian patent offices have allowed claims in respective patent applications covering methods for treating a wide range of autoimmune diseases using monoclonal antibodies that bind to the CD22 antigen present on B-lymphocytes.

16 Jun 2005

MabThera highly effective in treating rheumatoid arthritis

Results from the DANCER study presented today revealed that MabThera significantly improves symptoms in heavily treated patients who are affected by moderate-to-severe rheumatoid arthritis (RA), a painful and debilitating disease of the joints.

9 Jun 2005

Rheumatoid arthritis costs more to business and industry than almost any other disease

Speaking at a rheumatology congress in Vienna today (Thursday 9 June), USA experts estimated that RA costs employers over $4,000 more per person, per year.

9 Jun 2005

Rituximab, used to treat rheumatoid arthritis (RA) is safe and effective

Professor Paul Emery from the University of Leeds in the UK led the DANCER study (Double blind placebo controlled dose ranging study), designed to confirm the efficacy of rituximab for the treatment of patients with active RA who have failed to improve on one or more disease modifying anti-rheumatic drugs (DMARDs).

9 Jun 2005

Rheumatoid Arthritis News and Research

Latest Rheumatoid Arthritis News and Research

Pomegranate fruit extracts can block enzymes that contribute to osteoarthritis

Disease modifying activity of 2ME2 demonstrated in preclinical rheumatoid arthritis studies

Patients with primary biliary cirrhosis who are treated with methotrexate have an increased risk of death

New research says brightly-coloured fruit and veggies protects against arthritis

Brightly-coloured fruit and veg, may act as antioxidants - protect against rheumatoid arthritis

Discovery of gene that controls the speed at which patients develop tuberculosis

New hope for those deaf from immune system attack

Adalimumab and methotrexate is about five times more effective than methotrexate alone for rheumatoid arthritis

Abbott receives European approval to market Humira

Scientists discover how an HIV protein fragment shuts down an immune response

Patients with rheumatoid arthritis are at increased risk of coronary artery disease

Enzyme known as cathepsin G may be a target for anti-inflammatory treatments

Expression profiles and functional analyses of Wnt-related genes in human joint disorders

Immunomedics awarded U.S. and Australian patents

MabThera highly effective in treating rheumatoid arthritis

Rheumatoid arthritis costs more to business and industry than almost any other disease

Rituximab, used to treat rheumatoid arthritis (RA) is safe and effective

Arthritis patients still suffer as drugs guidelines are ignored

Gene therapy for arthritis is both feasible and safe

Better care for rheumatoid arthritis sufferers

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Rheumatoid Arthritis News and Research

Latest Rheumatoid Arthritis News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in